DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
Browsing Category
The current model of care in General Practice and community healthcare needs urgent reform. The focus should be on maximising efficiency, empowering pharmacies, and most importantly, respecting the patient’s time. As closures increase and inefficiencies pile up, it is only a matter of time before more patients fall through the cracks, unless meaningful action is taken now.
Antidepressant use has soared over the past two decades, with the UK alone seeing a doubling in prescriptions since 2008. While medication can be life-changing for some, concerns are growing around its overprescription, especially for patients who may not need long-term pharmacological treatment. From the reluctance of GPs to offer fast-acting relief to the alarming trend of children being medicated, it’s time to ask, are we medicating emotion at the expense of wellbeing?
In an era where innovation is at the forefront of healthcare, one fundamental aspect remains overlooked: accessibility and sustainability in pharmaceutical packaging. While the UK pharmaceutical industry, commonly referred to as “Big Pharma,” is known for its cutting-edge research and distribution networks, the end-user experience, particularly among vulnerable groups such as the elderly, disabled, and those with mental health challenges, is often ignored.
As weight loss injections dominate the headlines, many wonder whether these so-called miracle drugs are truly safe, what happens if you stop taking them, and whether your GP can prescribe them. Here’s what you need to know.
The potential for psychedelic mushrooms to treat mental health disorders is becoming increasingly clear. As more research demonstrates their safety and efficacy, it is likely that psilocybin-assisted therapy will become more widely available, with doctors able to prescribe controlled doses in therapeutic settings.
Psychedelic mushrooms hold immense promise for revolutionizing mental health treatment, backed by compelling scientific evidence. However, their path to legalization is obstructed by historical, regulatory, and societal barriers.
The Committee is urging the Government to evaluate whether the mothballed Rosalind Franklin Laboratory in the West Midlands could serve as an appropriate facility. The Laboratory, which has already received over £1 billion in public funding, was established to address the testing capacity shortcomings that hindered the national response to COVID-19. It features modern, secure laboratory facilities and was intended to enhance national resilience against future pandemics. Yet, to the surprise of the scientific and health communities, the Rosalind Franklin Laboratory has recently appeared for sale on the property website Rightmove.
Please Note: Drug shortages can vary over time due to a range of factors including manufacturing issues, regulatory challenges, supply chain disruptions, and changes in demand. Community Pharmacy England or the UK’s Department of Health and Social Care may provide up-to-date information on drug shortages in the UK. Checking their official websites or contacting them directly would be the best way to obtain the most current information on drug shortages in the UK.
In a significant development, pharmaceutical giant AstraZeneca has announced the worldwide withdrawal of its COVID-19 vaccine. The decision comes in the wake of mounting concerns over rare cases of blood clotting associated with the vaccine.
As the MHRA tightens its oversight of Kenalog advertising, it sends a clear message that the promotion of medications must prioritize patient safety above all else. By fostering transparency and accountability in pharmaceutical marketing, regulatory authorities can help safeguard the well-being of individuals who rely on these medications for their health needs.